Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation

References

• Lammers T, Kiessling F, Hennink WE, et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release. 2012;161:175–187
   PubMed Web of Science ®Google Scholar
• Shi JJ, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20–37.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–760.
   PubMed Web of Science ®Google Scholar
• Venditto VJ, Szoka FC. Cancer nanomedicines: so many papers and so few drugs! Adv Drug Deliv Rev. 2013;65:80–88.
   PubMed Web of Science ®Google Scholar
• van der Meel R, Lammers T, Hennink WE. Cancer nanomedicines: oversold or underappreciated?. Expert Opin Drug Deliv. 2017;14:1–5.
   PubMed Web of Science ®Google Scholar
• Nichols JW, Bae YH. EPR: evidence and fallacy. J Control Release. 2014;190:451–464.
   PubMed Web of Science ®Google Scholar
• Gerber HP, Senter PD, Grewal IS. Antibody drug-conjugates targeting the tumor vasculature: current and future developments. MAbs. 2009;1:247–253.
   PubMed Web of Science ®Google Scholar
• Kurdziel KA, Kalen JD, Hirsch JI, et al. Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT. J Nucl Med. 2011;52:1339–1345.
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7:653–664.
   PubMed Web of Science ®Google Scholar
• Fukumura D, Jain RK. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem. 2007;101:937–949.
   PubMed Web of Science ®Google Scholar
• Reitan NK, Thuen M, Goa PE, et al. Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging. J Biomed Opt. 2010;15:036004.
   PubMed Web of Science ®Google Scholar
• He C, Chan C, Weichselbaum RR, et al. Nanomedicine for combination therapy of cancer. EBioMedicine. 2015;2:366–367.
   PubMed Web of Science ®Google Scholar
• Maeda H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev. 2015;91:3–6.
   PubMed Web of Science ®Google Scholar
• Prabhakar U, Maeda H, Jain RK, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res. 2013;73:2412–2417.
   PubMed Web of Science ®Google Scholar
• Netti PA, Berk DA, Swartz MA, et al. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 2000;60:2497–2503.
   PubMed Web of Science ®Google Scholar
• Eikenes L, Bruland OS, Brekken C, et al. Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res. 2004;64:4768–4773.
   PubMed Web of Science ®Google Scholar
• Eikenes L, Tari M, Tufto I, et al. Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx (TM)) in human osteosarcoma xenografts. Br J Cancer. 2005;93:81–88.
   PubMed Web of Science ®Google Scholar
• Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res. 1990;50:4478–4484.
   PubMed Web of Science ®Google Scholar
• Chauhan VP, Stylianopoulos T, Boucher Y, et al. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng. 2011;2:281–298.
   PubMed Web of Science ®Google Scholar
• Dai Q, Wilhelm S, Ding D, et al. quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors. ACS Nano. 2018;12:8423–8435.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Tavares AJ, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1.
   Web of Science ®Google Scholar
• Abbott NJ, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13–25.
   PubMed Web of Science ®Google Scholar
• Ojha T, Pathak V, Shi Y, et al. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. Adv Drug Deliv Rev. 2017;119:44–60.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Watanabe R, Choyke PL. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics. 2013;4:81–89.
   PubMed Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12:991–1003.
   PubMed Web of Science ®Google Scholar
• Danhier F. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 2016;244:108–121.
   PubMed Web of Science ®Google Scholar
• Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153:198–205.
   PubMed Web of Science ®Google Scholar
• Rix A, Lederle W, Theek B, et al. advanced ultrasound technologies for diagnosis and therapy. J Nucl Med. 2018.
   PubMed Web of Science ®Google Scholar
• Sennoga CA, Kanbar E, Auboire L, et al. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring. Expert Opin Drug Deliv. 2017;14:1031–1043.
   PubMed Web of Science ®Google Scholar
• Lamsam L, Johnson E, Connolly ID, et al. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy. Neurosurg Focus. 2018;44:E10.
   PubMed Web of Science ®Google Scholar
• Husseini GA, Pitt WG, Martins AM. Ultrasonically triggered drug delivery: breaking the barrier. Colloids Surf B Biointerfaces. 2014;123:364–386.
   PubMed Web of Science ®Google Scholar
• Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev. 2008;60:1193–1208.
   PubMed Web of Science ®Google Scholar
• O’Brien WD Jr. Ultrasound-biophysics mechanisms. Prog Biophys Mol Biol. 2007;93:212–255.
   PubMed Web of Science ®Google Scholar
• Pitt WG, Husseini GA, Staples BJ. Ultrasonic drug delivery–a general review. Expert Opin Drug Deliv. 2004;1:37–56.
   PubMedGoogle Scholar
• Draper DO, Castel JC, Castel D. Rate of temperature increase in human muscle during 1 MHz and 3 MHz continuous ultrasound. J Orthop Sports Phys Ther. 1995;22:142–150.
   PubMed Web of Science ®Google Scholar
• Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol. 2003;76:590–599.
   PubMed Web of Science ®Google Scholar
• Huber PE, Jenne JW, Rastert R, et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res. 2001;61:8441–8447.
   PubMed Web of Science ®Google Scholar
• Grull H, Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release. 2012;161:317–327.
   PubMed Web of Science ®Google Scholar
• Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia. 1999;15:345–370.
   PubMed Web of Science ®Google Scholar
• Couture O, Foley J, Kassell NF, et al. Review of ultrasound mediated drug delivery for cancer treatment: updates from preclinical studies. Transl Cancer Res. 2014;3:494–511.
   Web of Science ®Google Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 1984;44:4721s–4730s.
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000;60:6950–6957.
   PubMed Web of Science ®Google Scholar
• Yudina A, Moonen C. Ultrasound-induced cell permeabilisation and hyperthermia: strategies for local delivery of compounds with intracellular mode of action. Int J Hyperthermia. 2012;28:311–319.
   PubMed Web of Science ®Google Scholar
• Jain A, Tiwari A, Verma A, et al. Ultrasound-based triggered drug delivery to tumors. Drug Deliv Transl Res. 2018;8:150–164.
   PubMed Web of Science ®Google Scholar
• Dayton P, Klibanov A, Brandenburger G, et al. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol. 1999;25:1195–1201.
   PubMed Web of Science ®Google Scholar
• Dymling SO, Persson HW, Hertz TG, et al. A new ultrasonic method for fluid property measurements. Ultrasound Med Biol. 1991;17:497–500.
   PubMed Web of Science ®Google Scholar
• Dimcevski G, Kotopoulis S, Bjanes T, et al. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. J Control Release. 2016;243:172–181.
   PubMed Web of Science ®Google Scholar
• Kotopoulis S, Dimcevski G, Gilja OH, et al. Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys. 2013;40. article no. 072902.
   PubMed Web of Science ®Google Scholar
• Carpentier A, Canney M, Vignot A, et al. Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016;8:343.
   Web of Science ®Google Scholar
• Lajoinie G, De Cock I, Coussios CC, et al. In vitro methods to study bubble-cell interactions: fundamentals and therapeutic applications. Biomicrofluidics. 2016;10:011501.
   PubMed Web of Science ®Google Scholar
• Lentacker I, De Cock I, Deckers R, et al. Understanding ultrasound induced sonoporation: definitions and underlying mechanisms. Adv Drug Deliv Rev. 2014;72:49–64.
   PubMed Web of Science ®Google Scholar
• Lammertink BHA, Bos C, Deckers R, et al. Sonochemotherapy:from bench to bedside. Front Pharmacol. 2015;6.
   PubMed Web of Science ®Google Scholar
• Boissenot T, Bordat A, Fattal E, et al. Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: from theoretical considerations to practical applications. J Control Release. 2016;241:144–163.
   PubMed Web of Science ®Google Scholar
• Liu HL, Fan CH, Ting CY, et al. Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview. Theranostics. 2014;4:432–444.
   PubMed Web of Science ®Google Scholar
• Hirabayashi F, Iwanaga K, Okinaga T, et al. Epidermal growth factor receptor-targeted sonoporation with microbubbles enhances therapeutic efficacy in a squamous cell carcinoma model. Plos One. 2017;12.
   Web of Science ®Google Scholar
• Fan CH, Ting CY, Liu HL, et al. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials. 2013;34:2142–2155.
   PubMed Web of Science ®Google Scholar
• Yan F, Li L, Deng Z, et al. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J Control Release. 2013;166:246–255.
   PubMed Web of Science ®Google Scholar
• Kovacs Z, Werner B, Rassi A, et al. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Control Release. 2014;187:74–82.
   PubMed Web of Science ®Google Scholar
• Luo W, Wen G, Yang L, et al. Dual-targeted and pH-sensitive doxorubicin prodrug-microbubble complex with ultrasound for tumor treatment. Theranostics. 2017;7:452–465.
   PubMed Web of Science ®Google Scholar
• Lipsman N, Ironside S, Alkins R, et al. Initial experience of blood-brain barrier opening for chemotherapeutic-drug delivery to brain tumours by MR-guided focused ultrasound. Neuro Oncol. 2017;19:vi275.
   Google Scholar
• Ross JP, Cai X, Chiu JF, et al. Optical and atomic force microscopic studies on sonoporation. J Acoust Soc Am. 2002;111:1161–1164.
   PubMed Web of Science ®Google Scholar
• Bao S, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol. 1997;23:953–959.
   PubMed Web of Science ®Google Scholar
• Sheikov N, McDannold N, Sharma S, et al. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol. 2008;34:1093–1104.
   PubMed Web of Science ®Google Scholar
• Meijering BD, Juffermans LJ, van Wamel A, et al. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res. 2009;104:679–687.
   PubMed Web of Science ®Google Scholar
• Yuana Y, Jiang L, Lammertink BHA, et al. Microbubbles-assisted ultrasound triggers the release of extracellular vesicles. Int J Mol Sci. 2017;18.
   PubMed Web of Science ®Google Scholar
• Rix A, Palmowski M, Gremse F, et al. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements. Ultrasound Med Biol. 2014;40:2468–2475.
   PubMed Web of Science ®Google Scholar
• Hersh DS, Nguyen BA, Dancy JG, et al. Pulsed ultrasound expands the extracellular and perivascular spaces of the brain. Brain Res. 2016;1646:543–550.
   PubMed Web of Science ®Google Scholar
• Collis J, Manasseh R, Liovic P, et al. Cavitation microstreaming and stress fields created by microbubbles. Ultrasonics. 2010;50:273–279.
   PubMed Web of Science ®Google Scholar
• Elder SA. Cavitation microstreaming. J Acoust Soc Am. 1959;31:54–64.
   Web of Science ®Google Scholar
• Kooiman K, Vos HJ, Versluis M, et al. Acoustic behavior of microbubbles and implications for drug delivery. Adv Drug Deliv Rev. 2014;72:28–48.
   PubMed Web of Science ®Google Scholar
• van Wamel A, Kooiman K, Harteveld M, et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release. 2006;112:149–155.
   PubMed Web of Science ®Google Scholar
• Poon C, McMahon D, Hynynen K. Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound. Neuropharmacology. 2017;120:20–37.
   PubMed Web of Science ®Google Scholar
• Schroeder A, Kost J, Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem Phys Lipids. 2009;162:1–16.
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Vykhodtseva N, et al. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology. 2001;220:640–646.
   PubMed Web of Science ®Google Scholar
• Hynynen K, McDannold N, Sheikov NA, et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005;24:12–20.
   PubMed Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Hynynen K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol. 2008;34:834–840.
   PubMed Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med Biol. 2008;34:930–937.
   PubMed Web of Science ®Google Scholar
• Samiotaki G, Konofagou EE. Dependence of the reversibility of focused- ultrasound-induced blood-brain barrier opening on pressure and pulse length in vivo. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60:2257–2265.
   PubMed Web of Science ®Google Scholar
• Pouliopoulos AN, Li C, Tinguely M, et al. Rapid short-pulse sequences enhance the spatiotemporal uniformity of acoustically driven microbubble activity during flow conditions. J Acoust Soc Am. 2016;140:2469.
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Liu M, Ojha T, et al. Ultrasound-mediated drug delivery to the brain: principles, progress and prospects. Drug Discov Today Technol. 2016;20:41–48.
   PubMedGoogle Scholar
• Burgess A, Dubey S, Yeung S, et al. Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior. Radiology. 2014;273:736–745.
   PubMed Web of Science ®Google Scholar
• O’Reilly MA, Hynynen K. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology. 2012;263:96–106.
   PubMed Web of Science ®Google Scholar
• Salgaonkar VA, Datta S, Holland CK, et al. Passive cavitation imaging with ultrasound arrays. J Acoust Soc Am. 2009;126:3071–3083.
   PubMed Web of Science ®Google Scholar
• Neppiras EA. Acoustic cavitation. Phys Rep. 1980;61:159–251.
   Web of Science ®Google Scholar
• Wu SK, Chu PC, Chai WY, et al. Characterization of different microbubbles in assisting focused ultrasound-induced blood-brain barrier opening. Sci Rep. 2017;7:46689.
   PubMed Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol. 2006;51:793–807.
   PubMed Web of Science ®Google Scholar
• Tung YS, Vlachos F, Choi JJ, et al. In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice. Phys Med Biol. 2010;55:6141–6155.
   PubMed Web of Science ®Google Scholar
• Delalande A, Kotopoulis S, Postema M, et al. Sonoporation: mechanistic insights and ongoing challenges for gene transfer. Gene. 2013;525:191–199.
   PubMed Web of Science ®Google Scholar
• Afadzi M, Strand SP, Nilssen EA, et al. Mechanisms of the ultrasound-mediated intracellular delivery of liposomes and dextrans. IEEE Trans Ultrason Ferroelectr Freq Control. 2013;60:21–33.
   PubMed Web of Science ®Google Scholar
• Dewitte H, Van Lint S, Heirman C, et al. The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy. J Control Release. 2014;194:28–36.
   PubMed Web of Science ®Google Scholar
• Karshafian R, Samac S, Bevan PD, et al. Microbubble mediated sonoporation of cells in suspension: clonogenic viability and influence of molecular size on uptake. Ultrasonics. 2010;50:691–697.
   PubMed Web of Science ®Google Scholar
• Fan Z, Liu H, Mayer M, et al. Spatiotemporally controlled single cell sonoporation. Proc Natl Acad Sci U S A. 2012;109:16486–16491.
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Luo YK, Lu CT, et al. Phospholipids-based microbubbles sonoporation pore size and reseal of cell membrane cultured in vitro. J Drug Target. 2008;16:18–25.
   PubMed Web of Science ®Google Scholar
• Hu Y, Wan JM, Yu AC. Membrane perforation and recovery dynamics in microbubble-mediated sonoporation. Ultrasound Med Biol. 2013;39:2393–2405.
   PubMed Web of Science ®Google Scholar
• Yudina A, Lepetit-Coiffe M, Moonen CT. Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement. Mol Imaging Biol. 2011;13:239–249.
   PubMed Web of Science ®Google Scholar
• Skachkov I, Luan Y, van der Steen A, et al. Targeted microbubble mediated sonoporation of endothelial cells in vivo. IEEE Trans Ultrason Ferroelectr Freq Control. 2014;61:1661–1667.
   PubMed Web of Science ®Google Scholar
• van Wamel A, Sontum PC, Healey A, et al. Acoustic cluster therapy (ACT) enhances the therapeutic efficacy of paclitaxel and Abraxane(R) for treatment of human prostate adenocarcinoma in mice. J Control Release. 2016;236:15–21.
   PubMed Web of Science ®Google Scholar
• Burke CW, Alexander ET, Timbie K, et al. Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival. Mol Ther. 2014;22:321–328.
   PubMed Web of Science ®Google Scholar
• Kotopoulis S, Delalande A, Popa M, et al. Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Mol Imaging Biol. 2014;16:53–62.
   PubMed Web of Science ®Google Scholar
• Lin CY, Huang YL, Li JR, et al. Effects of focused ultrasound and microbubbles on the vascular permeability of nanoparticles delivered into mouse tumors. Ultrasound Med Biol. 2010;36:1460–1469.
   PubMed Web of Science ®Google Scholar
• Lin CY, Li JR, Tseng HC, et al. Enhancement of focused ultrasound with microbubbles on the treatments of anticancer nanodrug in mouse tumors. Nanomedicine. 2012;8:900–907.
   PubMed Web of Science ®Google Scholar
• Wang TY, Choe JW, Pu K, et al. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer. J Control Release. 2015;203:99–108.
   PubMed Web of Science ®Google Scholar
• Lin CY, Liu TM, Chen CY, et al. Quantitative and qualitative investigation into the impact of focused ultrasound with microbubbles on the triggered release of nanoparticles from vasculature in mouse tumors. J Control Release. 2010;146:291–298.
   PubMed Web of Science ®Google Scholar
• Hersh DS, Wadajkar AS, Roberts N, et al. Evolving drug delivery strategies to overcome the blood brain barrier. Curr Pharm Des. 2016;22:1177–1193.
   PubMed Web of Science ®Google Scholar
• Sheikov N, McDannold N, Vykhodtseva N, et al. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol. 2004;30:979–989.
   PubMed Web of Science ®Google Scholar
• Zhao B, Chen Y, Liu J, et al. Blood-brain barrier disruption induced by diagnostic ultrasound combined with microbubbles in mice. Oncotarget. 2018;9:4897–4914.
   PubMedGoogle Scholar
• Sheikov N, McDannold N, Jolesz F, et al. Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med Biol. 2006;32:1399–1409.
   PubMed Web of Science ®Google Scholar
• Deng J, Huang Q, Wang F, et al. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles. J Mol Neurosci. 2012;46:677–687.
   PubMed Web of Science ®Google Scholar
• Aryal M, Fischer K, Gentile C, et al. Effects on P-glycoprotein expression after blood-brain barrier disruption using focused ultrasound and microbubbles. Plos One. 2017;12:e0166061.
   PubMed Web of Science ®Google Scholar
• Cho H, Lee HY, Han M, et al. Localized down-regulation of p-glycoprotein by focused ultrasound and microbubbles induced blood-brain barrier disruption in rat brain. Sci Rep. 2016;6:31201.
   PubMed Web of Science ®Google Scholar
• Hadaczek P, Yamashita Y, Mirek H, et al. The “perivascular pump” driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther. 2006;14:69–78.
   PubMed Web of Science ®Google Scholar
• Chen H, Yang GZ, Getachew H, et al. Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor. Sci Rep. 2016;6:28599.
   PubMed Web of Science ®Google Scholar
• Raymond SB, Skoch J, Hynynen K, et al. Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. J Cereb Blood Flow Metab. 2007;27:393–403.
   PubMed Web of Science ®Google Scholar
• Goertz DE, Todorova M, Mortazavi O, et al. Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles. Plos One. 2012;7:e52307.
   PubMed Web of Science ®Google Scholar
• Keravnou CP, De Cock I, Lentacker I, et al. Microvascular injury and perfusion changes induced by ultrasound and microbubbles in a machine-perfused pig liver. Ultrasound Med Biol. 2016;42:2676–2686.
   PubMed Web of Science ®Google Scholar
• Hu X, Kheirolomoom A, Mahakian LM, et al. Insonation of targeted microbubbles produces regions of reduced blood flow within tumor vasculature. Invest Radiol. 2012;47:398–405.
   PubMed Web of Science ®Google Scholar
• El Kaffas A, Gangeh MJ, Farhat G, et al. Tumour vascular shutdown and cell death following ultrasound-microbubble enhanced radiation therapy. Theranostics. 2018;8:314–327.
   PubMed Web of Science ®Google Scholar
• Belcik JT, Mott BH, Xie A, et al. Augmentation of limb perfusion and reversal of tissue ischemia produced by ultrasound-mediated microbubble cavitation. Circ Cardiovasc Imaging. 2015;8.
   Web of Science ®Google Scholar
• Paefgen V, Doleschel D, Kiessling F. Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front Pharmacol. 2015;6:197.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Klibanov AL. Co-administration of microbubbles and drugs in ultrasound-assisted drug delivery: comparison with drug-carrying particles. Adv Exp Med Biol. 2016;880:205–220.
   PubMed Web of Science ®Google Scholar
• Lentacker I, Smedt SCD, Sanders NN. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter. 2009;5:2161–2170.
   Web of Science ®Google Scholar
• Kiessling F, Fokong S, Koczera P, et al. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med. 2012;53:345–348.
   PubMed Web of Science ®Google Scholar
• Theek B, Baues M, Ojha T, et al. Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. J Control Release. 2016;231:77–85.
   PubMed Web of Science ®Google Scholar
• De Temmerman ML, Dewitte H, Vandenbroucke RE, et al. mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells. Biomaterials. 2011;32:9128–9135.
   PubMed Web of Science ®Google Scholar
• Burke CW, Hsiang YHJ, Alexander E, et al. Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle. Small. 2011;7:1227–1235.
   PubMed Web of Science ®Google Scholar
• De Cock I, Lajoinie G, Versluis M, et al. Sonoprinting and the importance of microbubble loading for the ultrasound mediated cellular delivery of nanoparticles. Biomaterials. 2016;83:294–307.
   PubMed Web of Science ®Google Scholar
• Snipstad S, Berg S, Morch Y, et al. Ultrasound improves the delivery and therapeutic effect of nanoparticle-stabilized microbubbles in breast cancer xenografts. Ultrasound Med Biol. 2017;43:2651–2669.
   PubMed Web of Science ®Google Scholar
• Koczera P, Appold L, Shi Y, et al. PBCA-based polymeric microbubbles for molecular imaging and drug delivery. J Control Release. 2017;259:128–135.
   PubMed Web of Science ®Google Scholar
• Rapoport N. Drug-loaded perfluorocarbon nanodroplets for ultrasound-mediated drug delivery. Ther Ultrasound. 2016;880:221–241.
   Web of Science ®Google Scholar
• Silpe JE, Nunes JK, Poortinga AT, et al. Generation of antibubbles from core-shell double emulsion templates produced by microfluidics. Langmuir. 2013;29:8782–8787.
   PubMed Web of Science ®Google Scholar
• Hughes A, Hynynen K. Design of patient-specific focused ultrasound arrays for non-invasive brain therapy with increased trans-skull transmission and steering range. Phys Med Biol. 2017;62:L9–L19.
   PubMed Web of Science ®Google Scholar
• Li ZG, Liu AQ, Klaseboer E, et al. Single cell membrane poration by bubble-induced microjets in a microfluidic chip. Lab Chip. 2013;13:1144–1150.
   PubMed Web of Science ®Google Scholar
• Helfield B, Chen X, Watkins SC, et al. Biophysical insight into mechanisms of sonoporation. Proc Natl Acad Sci U S A. 2016;113:9983–9988.
   PubMed Web of Science ®Google Scholar
• De Cock I, Zagato E, Braeckmans K, et al. Ultrasound and microbubble mediated drug delivery: acoustic pressure as determinant for uptake via membrane pores or endocytosis. J Control Release. 2015;197:20–28.
   PubMed Web of Science ®Google Scholar
• Grainger SJ, Serna JV, Sunny S, et al. Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids. Mol Pharm. 2010;7:2006–2019.
   PubMedGoogle Scholar
• Park YC, Zhang C, Kim S, et al. Microvessels-on-a-chip to assess targeted ultrasound-assisted drug delivery. ACS Appl Mater Interfaces. 2016;8:31541–31549.
   PubMed Web of Science ®Google Scholar
• Herland A, van der Meer AD, FitzGerald EA, et al. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip. Plos One. 2016;11:e0150360.
   PubMed Web of Science ®Google Scholar
• Maoz BM, Herland A, FitzGerald EA, et al. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells. Nat Biotechnol. 2018.
   PubMed Web of Science ®Google Scholar
• Chen H, Brayman AA, Matula TJ. Characteristic microvessel relaxation timescales associated with ultrasound-activated microbubbles. Appl Phys Lett. 2012;101:163704.
   PubMed Web of Science ®Google Scholar
• Hosseinkhah N, Chen H, Matula TJ, et al. Mechanisms of microbubble-vessel interactions and induced stresses: a numerical study. J Acoust Soc Am. 2013;134:1875–1885.
   PubMed Web of Science ®Google Scholar
• van Wamel A, Bouakaz A, Versluis M, et al. Micromanipulation of endothelial cells: ultrasound-microbubble-cell interaction. Ultrasound Med Biol. 2004;30:1255–1258.
   PubMed Web of Science ®Google Scholar
• Kudo N, Okada K, Yamamoto K. Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells. Biophys J. 2009;96:4866–4876.
   PubMed Web of Science ®Google Scholar
• Prentice P, Cuschieri A, Dholakia K, et al. Membrane disruption by optically controlled microbubble cavitation. Nat Phys. 2005;1:107–110.
   Web of Science ®Google Scholar
• Mehier-Humbert S, Bettinger T, Yan F, et al. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J Control Release. 2005;104:213–222.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang K, Cui J, et al. Controlled permeation of cell membrane by single bubble acoustic cavitation. J Control Release. 2012;157:103–111.
   PubMed Web of Science ®Google Scholar
• Fan L, Liu Y, Ying H, et al. Increasing of blood-tumor barrier permeability through paracellular pathway by low-frequency ultrasound irradiation in vitro. J Mol Neurosci. 2011;43:541–548.
   PubMed Web of Science ®Google Scholar
• Kooiman K, Foppen-Harteveld M, van der Steen AF, et al. Sonoporation of endothelial cells by vibrating targeted microbubbles. J Control Release. 2011;154:35–41.
   PubMed Web of Science ®Google Scholar
• Dewitte H, Vanderperren K, Haers H, et al. Theranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery. Theranostics. 2015;5:97–109.
   PubMed Web of Science ®Google Scholar
• Song K-H, Harvey BK, Borden MA. State-of-the-art of microbubble-assisted blood-brain barrier disruption. Theranostics. 2018;8:4393–4408.
   PubMed Web of Science ®Google Scholar
• Escoffre JM, Deckers R, Bos C, et al. Bubble-assisted ultrasound: application in immunotherapy and vaccination. Adv Exp Med Biol. 2016;880:243–261.
   PubMed Web of Science ®Google Scholar
• Burgess A, Hynynen K. Microbubble-assisted ultrasound for drug delivery in the brain and central nervous system. Adv Exp Med Biol. 2016;880:293–308.
   PubMed Web of Science ®Google Scholar
• Park J, Aryal M, Vykhodtseva N, et al. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J Control Release. 2017;250:77–85.
   PubMed Web of Science ®Google Scholar
• Aslund AKO, Berg S, Hak S, et al. Nanoparticle delivery to the brain–by focused ultrasound and self-assembled nanoparticle-stabilized microbubbles. J Control Release. 2015;220:287–294.
   PubMed Web of Science ®Google Scholar
• Treat LH, McDannold N, Zhang Y, et al. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol. 2012;38:1716–1725.
   PubMed Web of Science ®Google Scholar
• Aryal M, Vykhodtseva N, Zhang YZ, et al. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release. 2013;169:103–111.
   PubMed Web of Science ®Google Scholar
• Park EJ, Zhang YZ, Vykhodtseva N, et al. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release. 2012;163:277–284.
   PubMed Web of Science ®Google Scholar
• Kobus T, Zervantonakis IK, Zhang Y, et al. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption. J Control Release. 2016;238:281–288.
   PubMed Web of Science ®Google Scholar
• Kinoshita M, McDannold N, Jolesz FA, et al. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci U S A. 2006;103:11719–11723.
   PubMed Web of Science ®Google Scholar
• Chen PY, Hsieh HY, Huang CY, et al. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study. J Transl Med. 2015;13:93.
   PubMed Web of Science ®Google Scholar
• Alkins R, Burgess A, Ganguly M, et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 2013;73:1892–1899.
   PubMed Web of Science ®Google Scholar
• Alkins R, Burgess A, Kerbel R, et al. Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival. Neuro Oncol. 2016;18:974–981.
   PubMed Web of Science ®Google Scholar
• Marquet F, Tung YS, Teichert T, et al. Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo. Plos One. 2011;6:e22598.
   PubMed Web of Science ®Google Scholar
• Downs ME, Buch A, Karakatsani ME, et al. Blood-brain barrier opening in behaving non-human primates via focused ultrasound with systemically administered microbubbles. Sci Rep-UK. 2015;5. article no. 15076.
   PubMed Web of Science ®Google Scholar
• Aslund AK, Snipstad S, Healey A, et al. Efficient enhancement of blood-brain barrier permeability using acoustic cluster therapy (ACT). Theranostics. 2017;7:23–30.
   PubMed Web of Science ®Google Scholar
• Marty B, Larrat B, Van Landeghem M, et al. Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis. J Cereb Blood Flow Metab. 2012;32:1948–1958.
   PubMed Web of Science ®Google Scholar
• Kovacs ZI, Burks SR, Frank JA. Concerning sterile inflammation following focused ultrasound and microbubbles in the brain. Proc Natl Acad Sci USA. 2017;114:E6737–E6738.
   Web of Science ®Google Scholar
• Kovacs ZI, Kim S, Jikaria N, et al. Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation. Proc Natl Acad Sci U S A. 2017;114:E75–E84.
   PubMed Web of Science ®Google Scholar
• Silburt J, Lipsman N, Aubert I. Disrupting the blood-brain barrier with focused ultrasound: perspectives on inflammation and regeneration. Proc Natl Acad Sci USA. 2017;114:E6735–E6736.
   Web of Science ®Google Scholar
• McDannold N, Vykhodtseva N, Raymond S, et al. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol. 2005;31:1527–1537.
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YZ, Power C, et al. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model. Proc Natl Acad Sci USA. 2017;114:E10281–E10290.
   PubMed Web of Science ®Google Scholar
• Jordao JF, Ayala-Grosso CA, Markham K, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer’s disease. Plos One. 2010;5:e10549.
   PubMed Web of Science ®Google Scholar
• Jordao JF, Thevenot E, Markham-Coultes K, et al. Amyloid-beta plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol. 2013;248:16–29.
   PubMed Web of Science ®Google Scholar
• Raymond SB, Treat LH, Dewey JD, et al. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer’s disease mouse models. Plos One. 2008;3:e2175.
   PubMed Web of Science ®Google Scholar
• Burgess A, Huang Y, Querbes W, et al. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J Control Release. 2012;163:125–129.
   PubMed Web of Science ®Google Scholar
• Konofagou EE, Neurorestoration of the nigrostriatal pathway through multiple treatments with FUS-facilitated brain drug delivery, Abstract, 22nd European symposium on Ultrasound Contrast Imaging, Rotterdam, (2017).
   Google Scholar
• Burgess A, Ayala-Grosso CA, Ganguly M, et al. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. Plos One. 2011;6:e27877.
   PubMed Web of Science ®Google Scholar
• Huang Q, Deng J, Xie Z, et al. Effective gene transfer into central nervous system following ultrasound-microbubbles-induced opening of the blood-brain barrier. Ultrasound Med Biol. 2012;38:1234–1243.
   PubMed Web of Science ®Google Scholar
• Thevenot E, Jordao JF, O’Reilly MA, et al. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Hum Gene Ther. 2012;23:1144–1155.
   PubMed Web of Science ®Google Scholar
• Wang S, Olumolade OO, Sun T, et al. Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus. Gene Ther. 2015;22:104–110.
   PubMed Web of Science ®Google Scholar
• Auboire L, Sennoga CA, Hyvelin JM, et al. Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies. Plos One. 2018;13:e0191788.
   PubMed Web of Science ®Google Scholar
• Jones RM, Deng L, Leung K, et al. Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening. Theranostics. 2018;8:2909–2926.
   PubMed Web of Science ®Google Scholar
• Wamel AV, Healey A, Sontum PC, et al. Acoustic cluster therapy (ACT) - pre-clinical proof of principle for local drug delivery and enhanced uptake. J Control Release. 2016;224:158–164.
   PubMed Web of Science ®Google Scholar
• Hu ZSI, McArthur HL, Ho AY. The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer?. Curr Breast Cancer Rep. 2017;9:45–51.
   PubMed Web of Science ®Google Scholar
• Ngwa W, Irabor OC, Schoenfeld JD, et al. Using immunotherapy to boost the abscopal effect. Nat Rev Cancer. 2018;18:313–322.
   PubMed Web of Science ®Google Scholar